Which systemic medication is commonly used as first-line therapy for postherpetic neuralgia?

Which systemic medication is commonly used as first-line therapy for postherpetic neuralgia?

• A. Opioids as needed
• B. Gabapentin or TCAs
• C. NSAIDs
• D. Acetaminophen

Answer: (B)

Postherpetic neuralgia is a neuropathic pain syndrome, so the first-line systemic treatments are those that target nerve signaling rather than just inflammation. Gabapentin (a gabapentinoid) and tricyclic antidepressants address the abnormal nerve activity underlying neuropathic pain. Gabapentin binds to the α2δ subunit of voltage-gated calcium channels in the spinal cord, reducing the release of excitatory neurotransmitters and dampening ectopic nerve firing. TCAs, such as amitriptyline or nortriptyline, increase levels of norepinephrine and serotonin by inhibiting their reuptake, which strengthens descending inhibitory pain pathways and modulates central pain processing. These mechanisms make them more effective for neuropathic pain like PHN than plain analgesics. In contrast, NSAIDs and acetaminophen target inflammatory or nociceptive pain and often provide limited relief for neuropathic pain. Opioids can be used for more refractory cases but carry risks of dependence and side effects, so they’re not considered first-line for PHN. Therefore, gabapentin or TCAs are the best first-line systemic options for postherpetic neuralgia.

Postherpetic neuralgia is a neuropathic pain syndrome, so the first-line systemic treatments are those that target nerve signaling rather than just inflammation. Gabapentin (a gabapentinoid) and tricyclic antidepressants address the abnormal nerve activity underlying neuropathic pain. Gabapentin binds to the α2δ subunit of voltage-gated calcium channels in the spinal cord, reducing the release of excitatory neurotransmitters and dampening ectopic nerve firing. TCAs, such as amitriptyline or nortriptyline, increase levels of norepinephrine and serotonin by inhibiting their reuptake, which strengthens descending inhibitory pain pathways and modulates central pain processing. These mechanisms make them more effective for neuropathic pain like PHN than plain analgesics.

In contrast, NSAIDs and acetaminophen target inflammatory or nociceptive pain and often provide limited relief for neuropathic pain. Opioids can be used for more refractory cases but carry risks of dependence and side effects, so they’re not considered first-line for PHN.

Therefore, gabapentin or TCAs are the best first-line systemic options for postherpetic neuralgia.